• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从香菇衍生的囊泡样纳米颗粒中鉴定出一种针对 SARS-CoV-2 奥密克戎变异株的新型抗病毒凝集素。

Identification of a Novel Antiviral Lectin against SARS-CoV-2 Omicron Variant from Shiitake-Mushroom-Derived Vesicle-like Nanoparticles.

机构信息

Nebraska Center for Virology, University of Nebraska-Lincoln, Morrison Center 143, 4240 Fair Street, Lincoln, NE 68583, USA.

School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.

出版信息

Viruses. 2024 Sep 30;16(10):1546. doi: 10.3390/v16101546.

DOI:10.3390/v16101546
PMID:39459880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11512411/
Abstract

Lectins are a class of carbohydrate-binding proteins that may have antiviral activity by binding to the glycans on the virion surface to interfere with viral entry. We have identified a novel lectin (named Shictin) from Shiitake mushroom ()-derived vesicle-like nanoparticles (VLNs, or exosomes) that exhibits strong activity against the SARS-CoV-2 Omicron variant with an IC value of 87 nM. Shictin contains 298 amino acids and consists of two unique domains (N-terminal and C-terminal domain). The N-terminal domain is the carbohydrate-binding domain (CBD) that is homologous with CBDs of other lectins, suggesting that Shictin inhibits SARS-CoV-2 infection by binding to the glycans on the virion surface to prevent viral entry. This finding demonstrates that exosomes of vegetables are a valuable source for the identification of antiviral lectins. Therefore, it is believed that lectins from vegetable VLNs have potential as antiviral therapeutic agents.

摘要

凝集素是一类糖结合蛋白,通过与病毒表面的聚糖结合来干扰病毒进入,从而可能具有抗病毒活性。我们从香菇衍生的囊泡样纳米颗粒(VLN,即外泌体)中鉴定出一种新型凝集素(命名为 Shictin),对 SARS-CoV-2 奥密克戎变异株具有很强的活性,IC 值为 87 nM。Shictin 含有 298 个氨基酸,由两个独特的结构域(N 端和 C 端结构域)组成。N 端结构域是碳水化合物结合结构域(CBD),与其他凝集素的 CBD 同源,表明 Shictin 通过与病毒表面的聚糖结合来抑制 SARS-CoV-2 感染,从而阻止病毒进入。这一发现表明蔬菜外泌体是鉴定抗病毒凝集素的有价值来源。因此,人们认为蔬菜 VLN 中的凝集素具有作为抗病毒治疗剂的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/856f22059368/viruses-16-01546-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/27d99f05514a/viruses-16-01546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/38dd49fc02c9/viruses-16-01546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/a64cd7cc8e52/viruses-16-01546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/202d9dd79abc/viruses-16-01546-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/3968c58e6bcf/viruses-16-01546-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/265e013e3e86/viruses-16-01546-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/fd7b0eb924c1/viruses-16-01546-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/856f22059368/viruses-16-01546-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/27d99f05514a/viruses-16-01546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/38dd49fc02c9/viruses-16-01546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/a64cd7cc8e52/viruses-16-01546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/202d9dd79abc/viruses-16-01546-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/3968c58e6bcf/viruses-16-01546-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/265e013e3e86/viruses-16-01546-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/fd7b0eb924c1/viruses-16-01546-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcec/11512411/856f22059368/viruses-16-01546-g008.jpg

相似文献

1
Identification of a Novel Antiviral Lectin against SARS-CoV-2 Omicron Variant from Shiitake-Mushroom-Derived Vesicle-like Nanoparticles.从香菇衍生的囊泡样纳米颗粒中鉴定出一种针对 SARS-CoV-2 奥密克戎变异株的新型抗病毒凝集素。
Viruses. 2024 Sep 30;16(10):1546. doi: 10.3390/v16101546.
2
Molecular basis of N-glycan recognition by pradimicin a and its potential as a SARS-CoV-2 entry inhibitor.普拉地霉素 A 识别 N-聚糖的分子基础及其作为 SARS-CoV-2 进入抑制剂的潜力。
Bioorg Med Chem. 2024 May 1;105:117732. doi: 10.1016/j.bmc.2024.117732. Epub 2024 Apr 18.
3
Lectin from (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta.(小麦胚芽凝集素)中的凝集素可抑制 SARS-CoV-2 及其关注的 Alpha 和 Beta 变体的感染。
Int J Mol Sci. 2021 Sep 22;22(19):10205. doi: 10.3390/ijms221910205.
4
Proteome Analysis and In Vitro Antiviral, Anticancer and Antioxidant Capacities of the Aqueous Extracts of and Edible Mushrooms.菌物药和食药用菌水提物的蛋白质组分析及体外抗病毒、抗癌和抗氧化活性研究
Molecules. 2021 Jul 30;26(15):4623. doi: 10.3390/molecules26154623.
5
Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.植物、真菌、藻类和蓝藻中的人特异性凝集素,作为 SARS-CoV、MERS-CoV 和 SARS-CoV-2(COVID-19)冠状病毒的潜在阻滞剂:生物医学视角。
Cells. 2021 Jun 28;10(7):1619. doi: 10.3390/cells10071619.
6
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.SRX3177,一种CDK4/6-PI3K-BET抑制剂,与一种RNA依赖性RNA聚合酶(RdRp)抑制剂莫努匹韦或一种进入抑制剂MU-UNMC-2联合使用时,对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的奥密克戎变种具有强大的抗病毒活性。
Antiviral Res. 2024 Jul;227:105904. doi: 10.1016/j.antiviral.2024.105904. Epub 2024 May 8.
7
Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.SARS-CoV-2 及其新兴变异株的进入抑制剂的发现和评估。
J Virol. 2021 Nov 23;95(24):e0143721. doi: 10.1128/JVI.01437-21. Epub 2021 Sep 22.
8
Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.ACE2 结合物抑制 ACE2-刺突蛋白相互作用可抑制 SARS-CoV-2 进入。
Angew Chem Int Ed Engl. 2022 Mar 7;61(11):e202115695. doi: 10.1002/anie.202115695. Epub 2022 Feb 1.
9
Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.金雀花凝集素及其基于金雀花凝集素的双价进入抑制剂抑制甲型流感病毒和严重急性呼吸综合征冠状病毒 2 型感染或共感染。
mBio. 2024 May 8;15(5):e0074124. doi: 10.1128/mbio.00741-24. Epub 2024 Apr 9.
10
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses.大麻二酚通过诱导宿主内质网应激和先天免疫反应来抑制 SARS-CoV-2 复制。
Sci Adv. 2022 Feb 25;8(8):eabi6110. doi: 10.1126/sciadv.abi6110. Epub 2022 Feb 23.

引用本文的文献

1
Heterozygous interferon signaling deficient mice as animal models for Chikungunya virus infection in the heart.杂合干扰素信号缺陷小鼠作为基孔肯雅病毒心脏感染的动物模型。
Sci Rep. 2025 May 23;15(1):18022. doi: 10.1038/s41598-025-02191-9.

本文引用的文献

1
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry.SARS-CoV-2 奥密克戎亚变种逐渐适应宿主细胞进入机制改变的人类细胞。
mSphere. 2024 Sep 25;9(9):e0033824. doi: 10.1128/msphere.00338-24. Epub 2024 Aug 27.
2
The Emergence and Evolution of SARS-CoV-2.SARS-CoV-2 的出现与演变。
Annu Rev Virol. 2024 Sep;11(1):21-42. doi: 10.1146/annurev-virology-093022-013037. Epub 2024 Aug 30.
3
Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A.
葱提取物和凝集素通过糖基识别抑制 SARS-CoV-2 及 Concanavalin A 作用模式的深入见解。
Antiviral Res. 2024 May;225:105856. doi: 10.1016/j.antiviral.2024.105856. Epub 2024 Mar 5.
4
Mannose-specific plant and microbial lectins as antiviral agents: A review.甘露糖特异性植物和微生物凝集素作为抗病毒药物:综述。
Glycoconj J. 2024 Feb;41(1):1-33. doi: 10.1007/s10719-023-10142-7. Epub 2024 Jan 20.
5
Lactic acid bacterial surface display of scytovirin inhibitors for anti-ebolavirus infection.用于抗埃博拉病毒感染的蓝藻素抑制剂的乳酸菌表面展示
Front Microbiol. 2023 Nov 23;14:1269869. doi: 10.3389/fmicb.2023.1269869. eCollection 2023.
6
The Antiviral Potential of Algal Lectins.藻类凝集素的抗病毒潜力。
Mar Drugs. 2023 Sep 28;21(10):515. doi: 10.3390/md21100515.
7
Exploring the Versatility of Exosomes: A Review on Isolation, Characterization, Detection Methods, and Diverse Applications.探索外泌体的多功能性:分离、表征、检测方法及多种应用的综述。
Anal Chem. 2023 Nov 7;95(44):16029-16048. doi: 10.1021/acs.analchem.3c02224. Epub 2023 Oct 24.
8
-Glycome Profile of the Spike Protein S1: Systemic and Comparative Analysis from Eleven Variants of SARS-CoV-2. Spike 蛋白 S1 的聚糖谱:来自 11 种 SARS-CoV-2 变体的系统和比较分析。
Biomolecules. 2023 Sep 20;13(9):1421. doi: 10.3390/biom13091421.
9
Plant Exosome-like Nanovesicles and Their Role in the Innovative Delivery of RNA Therapeutics.植物外泌体样纳米囊泡及其在RNA疗法创新递送中的作用。
Biomedicines. 2023 Jun 24;11(7):1806. doi: 10.3390/biomedicines11071806.
10
Analysis of the N-glycosylation profiles of the spike proteins from the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2.分析 SARS-CoV-2 的 Alpha、Beta、Gamma 和 Delta 变体的刺突蛋白的 N-糖基化谱。
Anal Bioanal Chem. 2023 Aug;415(19):4779-4793. doi: 10.1007/s00216-023-04771-y. Epub 2023 Jun 24.